DERMATITIS, ATOPIC
Clinical trials for DERMATITIS, ATOPIC explained in plain language.
Never miss a new study
Get alerted when new DERMATITIS, ATOPIC trials appear
Sign up with your email to follow new studies for DERMATITIS, ATOPIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection aims to tame severe eczema itch and rash
Disease control TerminatedThis study tested different doses of an injectable drug called GSK1070806 against a placebo in adults with moderate-to-severe atopic dermatitis (eczema). The main goal was to see how well the drug reduced the severity of skin rashes and itching over 16 weeks. Participants had pre…
Matched conditions: DERMATITIS, ATOPIC
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Extended trial tests eczema Drug's Long-Term safety
Disease control TerminatedThis study aimed to evaluate the long-term safety and effectiveness of an investigational drug called GSK1070806 for adults with moderate-to-severe atopic dermatitis (eczema). It was an extension study for 79 participants who had already completed a previous trial of the same dru…
Matched conditions: DERMATITIS, ATOPIC
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Doctors track new eczema Pill's Real-World impact
Knowledge-focused TerminatedThis study aimed to observe how well the prescription pill abrocitinib works and how safe it is for adults with moderate to severe eczema (atopic dermatitis) in real-world German clinics. It followed 112 patients who were already starting this medication as part of their normal c…
Matched conditions: DERMATITIS, ATOPIC
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:25 UTC